Ciliary dysfunction leads to a broad range of overlapping phenotypes, collectively termed
ciliopathies. This grouping is underscored by genetic overlap, where causal genes can also …

Alport syndrome inevitably leads to end-stage renal disease and there are no therapies
known to improve outcome. Here we determined whether angiotensin-converting enzyme …

With the increasing use of mycophenolic acid (MPA) in solid organ transplantation, the need
for more accurate drug dosing has become evident. Personalized immunosuppressive …

Background Growth hormone treatment stimulates growth in short children with chronic renal
failure. However, the extent to which this therapy increases final adult height is not known. …

Background. Fixed-dose mycophenolate mofetil (MMF) reduces the incidence of acute
rejection after solid organ transplantation. The Fixed-Dose Concentration Controlled trial …

ABSTRACT. It is currently being debated whether pharmacokinetic monitoring of mycophenolic
acid (MPA), the active constituent of mycophenolate mofetil (MMF), can optimize MMF …

PURPOSE: Hypokalemic salt-losing tubulopathies (Bartter-like syndromes) comprise a set
of clinically and genetically distinct inherited renal disorders. Mutations in four renal …

Importance School and daycare closures were enforced as measures to confine the novel
coronavirus disease 2019 (COVID-19) pandemic, based on the assumption that young …

When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy,
fixed doses were recommended by the manufacturer. Awareness of the potential for a more …

The quality and persistence of children’s humoral immune response following SARS-CoV-2
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …